Chargement en cours...
Effect of Ivacaftor on Objective and Subjective Measures of Cough in Patients with Cystic Fibrosis
BACKGROUND AND OBJECTIVES: Cough is a major symptom in cystic fibrosis. Ivacaftor is a novel drug which targets the G551D mutation and has been demonstrated to improve lung function and weight in the long term. It also improves symptoms of extra-oesophageal reflux. We wanted to evaluate the effect o...
Enregistré dans:
| Publié dans: | Open Respir Med J |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Bentham Open
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5299558/ https://ncbi.nlm.nih.gov/pubmed/28217196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874306401610010105 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|